Cardio Diagnostics Holdings, Inc. Operating Income
Cardio Diagnostics Holdings, Inc. (CDIO) reported Operating Income of -$1.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$1.50M.
- Cardio Diagnostics Holdings, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$1.78M.
- Cardio Diagnostics Holdings, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$1.46M.
- Cardio Diagnostics Holdings, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$1.71M.
- Cardio Diagnostics Holdings, Inc. operating income (loss) for fiscal 2025 was -$6.48M.
- Cardio Diagnostics Holdings, Inc. operating income (loss) for fiscal 2024 was -$8.37M.
- Cardio Diagnostics Holdings, Inc. operating income (loss) for fiscal 2023 was -$7.24M.
- Cardio Diagnostics Holdings, Inc. operating income (loss) for fiscal 2022 was -$4.55M.
| Period end | Operating Income (Loss) 1 month | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 4 month | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 7 month | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.50M 10-Q · filed 2026-08-07 | -$3.28M 10-Q · filed 2026-08-07 | -$4.75M derived: sum of 3 quarters · filed 2026-08-07 | -$6.46M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2026-03-31 | -$1.78M 10-Q · filed 2026-05-15 | -$3.25M derived: sum of 2 quarters · filed 2026-05-15 | -$4.96M derived: sum of 3 quarters · filed 2026-05-15 | -$6.64M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$3.17M derived: sum of 2 quarters · filed 2026-03-13 | -$4.85M derived: sum of 3 quarters · filed 2026-08-07 | -$6.48M 10-K · filed 2026-03-13 | ||||||
| 2025-09-30 | -$1.71M 10-Q · filed 2025-11-12 | -$3.39M derived: sum of 2 quarters · filed 2026-08-07 | -$5.02M 10-Q · filed 2025-11-12 | -$6.54M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-06-30 | -$1.68M 10-Q · filed 2026-08-07 | -$3.31M 10-Q · filed 2026-08-07 | -$4.83M derived: sum of 3 quarters · filed 2026-08-07 | -$6.23M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-03-31 | -$1.63M 10-Q · filed 2026-05-15 | -$3.15M derived: sum of 2 quarters · filed 2026-05-15 | -$4.56M derived: sum of 3 quarters · filed 2026-05-15 | -$5.84M derived: sum of 4 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$2.93M derived: sum of 2 quarters · filed 2026-03-13 | -$4.21M derived: sum of 3 quarters · filed 2026-03-13 | -$8.37M 10-K · filed 2026-03-13 | ||||||
| 2024-09-30 | -$1.41M 10-Q · filed 2025-11-12 | -$2.69M derived: sum of 2 quarters · filed 2025-11-12 | -$6.85M 10-Q · filed 2025-11-12 | -$8.39M derived: sum of 4 quarters · filed 2025-11-12 | ||||||
| 2024-06-30 | -$1.28M 10-Q · filed 2025-08-14 | -$5.44M 10-Q · filed 2025-08-14 | -$6.98M derived: sum of 3 quarters · filed 2025-08-14 | -$8.43M derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | -$4.16M 10-Q · filed 2025-05-15 | -$5.70M derived: sum of 2 quarters · filed 2025-05-15 | -$7.14M derived: sum of 3 quarters · filed 2025-05-15 | -$9.70M derived: sum of 4 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | -$1.54M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$2.99M derived: sum of 2 quarters · filed 2025-03-20 | -$5.54M derived: sum of 3 quarters · filed 2025-03-20 | -$7.24M 10-K · filed 2025-03-20 | ||||||
| 2023-09-30 | -$1.44M 10-Q · filed 2024-11-13 | -$4.00M derived: sum of 2 quarters · filed 2024-11-13 | -$5.70M 10-Q · filed 2024-11-13 | -$8.08M derived: sum of 4 quarters · filed 2024-11-13 | ||||||
| 2023-06-30 | -$2.55M 10-Q · filed 2024-08-12 | -$4.26M 10-Q · filed 2024-08-12 | -$6.63M derived: sum of 3 quarters · filed 2024-08-12 | -$7.79M derived: sum of 4 quarters · filed 2024-08-12 | ||||||
| 2023-03-31 | -$1.70M 10-Q · filed 2024-05-15 | -$4.08M derived: sum of 2 quarters · filed 2024-05-15 | -$5.23M derived: sum of 3 quarters · filed 2024-05-15 | -$6.02M derived: sum of 4 quarters · filed 2024-05-15 | ||||||
| 2022-12-31 | -$2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$3.53M derived: sum of 2 quarters · filed 2024-04-01 | -$4.32M derived: sum of 3 quarters · filed 2024-04-01 | -$4.55M 10-K · filed 2024-04-01 | ||||||
| 2022-09-30 | -$1.15M 10-Q · filed 2023-11-13 | -$165.29K 10-Q · filed 2022-11-07 | -$1.94M derived: sum of 2 quarters · filed 2023-11-13 | -$2.17M 10-Q · filed 2023-11-13 | -$890.96K 10-Q · filed 2022-11-07 | |||||
| 2022-06-30 | -$786.96K 10-Q · filed 2023-08-14 | -$498.58K 10-Q · filed 2022-08-10 | -$1.02M 10-Q · filed 2023-08-14 | -$725.67K 10-Q · filed 2022-08-10 | ||||||
| 2022-03-31 | -$227.09K 10-Q · filed 2022-05-12 | |||||||||
| 2021-12-31 | -$145.32K 10-K · filed 2022-03-31 | -$620.45K 10-K · filed 2023-03-31 | ||||||||
| 2021-09-30 | -$721.00 10-Q · filed 2022-11-07 | |||||||||
| 2021-06-30 | -$397.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |